Logo image of ALB

ALBEMARLE CORP (ALB) Stock Fundamental Analysis

NYSE:ALB - US0126531013 - Common Stock

78.94 USD
+0.82 (+1.05%)
Last: 8/21/2025, 8:04:00 PM
77.94 USD
-1 (-1.27%)
Pre-Market: 8/22/2025, 7:15:03 AM
Fundamental Rating

3

Overall ALB gets a fundamental rating of 3 out of 10. We evaluated ALB against 84 industry peers in the Chemicals industry. While ALB seems to be doing ok healthwise, there are quite some concerns on its profitability. ALB is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ALB has reported negative net income.
ALB had a positive operating cash flow in the past year.
Of the past 5 years ALB 4 years were profitable.
Each year in the past 5 years ALB had a positive operating cash flow.
ALB Yearly Net Income VS EBIT VS OCF VS FCFALB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

ALB's Return On Assets of -6.34% is on the low side compared to the rest of the industry. ALB is outperformed by 71.43% of its industry peers.
Looking at the Return On Equity, with a value of -10.70%, ALB is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA -6.34%
ROE -10.7%
ROIC N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ALB Yearly ROA, ROE, ROICALB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

Looking at the Gross Margin, with a value of 7.76%, ALB is doing worse than 86.90% of the companies in the same industry.
In the last couple of years the Gross Margin of ALB has declined.
ALB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
ALB Yearly Profit, Operating, Gross MarginsALB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

ALB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALB remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ALB has more shares outstanding
The debt/assets ratio for ALB has been reduced compared to a year ago.
ALB Yearly Shares OutstandingALB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ALB Yearly Total Debt VS Total AssetsALB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

ALB has an Altman-Z score of 1.65. This is a bad value and indicates that ALB is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.65, ALB is in line with its industry, outperforming 40.48% of the companies in the same industry.
A Debt/Equity ratio of 0.31 indicates that ALB is not too dependend on debt financing.
ALB's Debt to Equity ratio of 0.31 is fine compared to the rest of the industry. ALB outperforms 73.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 1.65
ROIC/WACCN/A
WACC8.38%
ALB Yearly LT Debt VS Equity VS FCFALB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 2.31 indicates that ALB has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.31, ALB is in the better half of the industry, outperforming 60.71% of the companies in the same industry.
ALB has a Quick Ratio of 1.47. This is a normal value and indicates that ALB is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.47, ALB is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 1.47
ALB Yearly Current Assets VS Current LiabilitesALB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ALB have decreased strongly by -155.42% in the last year.
ALB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -33.05%.
Measured over the past years, ALB shows a quite strong growth in Revenue. The Revenue has been growing by 8.42% on average per year.
EPS 1Y (TTM)-155.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
Revenue 1Y (TTM)-33.05%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-7.02%

3.2 Future

The Earnings Per Share is expected to grow by 63.36% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.24% on average over the next years. This is quite good.
EPS Next Y33.75%
EPS Next 2Y52.84%
EPS Next 3Y58.22%
EPS Next 5Y63.36%
Revenue Next Year-11.82%
Revenue Next 2Y-2.15%
Revenue Next 3Y3.93%
Revenue Next 5Y11.24%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALB Yearly Revenue VS EstimatesALB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
ALB Yearly EPS VS EstimatesALB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 100.39, which means the current valuation is very expensive for ALB.
ALB's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ALB is more expensive than 72.62% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.91, ALB is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 100.39
ALB Price Earnings VS Forward Price EarningsALB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALB indicates a slightly more expensive valuation: ALB is more expensive than 76.19% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.05
ALB Per share dataALB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALB does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as ALB's earnings are expected to grow with 58.22% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.84%
EPS Next 3Y58.22%

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.99%, ALB has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.59, ALB has a dividend in line with its industry peers.
ALB's Dividend Yield is comparable with the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 1.99%

5.2 History

The dividend of ALB is nicely growing with an annual growth rate of 13.04%!
ALB has paid a dividend for at least 10 years, which is a reliable track record.
ALB has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)13.04%
Div Incr Years30
Div Non Decr Years30
ALB Yearly Dividends per shareALB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

ALB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
ALB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-32.53%
EPS Next 2Y52.84%
EPS Next 3Y58.22%
ALB Yearly Income VS Free CF VS DividendALB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

More info and screens

ALBEMARLE CORP

NYSE:ALB (8/21/2025, 8:04:00 PM)

Premarket: 77.94 -1 (-1.27%)

78.94

+0.82 (+1.05%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners98.79%
Inst Owner Change0.81%
Ins Owners0.36%
Ins Owner Change18.16%
Market Cap9.29B
Analysts67.5
Price Target81.48 (3.22%)
Short Float %12.61%
Short Ratio3.25
Dividend
Industry RankSector Rank
Dividend Yield 1.99%
Yearly Dividend2.65
Dividend Growth(5Y)13.04%
DP-32.53%
Div Incr Years30
Div Non Decr Years30
Ex-Date09-12 2025-09-12 (0.405)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)91.46%
Min EPS beat(2)69.72%
Max EPS beat(2)113.21%
EPS beat(4)2
Avg EPS beat(4)-30.22%
Min EPS beat(4)-249.28%
Max EPS beat(4)113.21%
EPS beat(8)3
Avg EPS beat(8)-20.6%
EPS beat(12)7
Avg EPS beat(12)-3.87%
EPS beat(16)11
Avg EPS beat(16)2.43%
Revenue beat(2)1
Avg Revenue beat(2)0.26%
Min Revenue beat(2)-7.88%
Max Revenue beat(2)8.39%
Revenue beat(4)1
Avg Revenue beat(4)-2.61%
Min Revenue beat(4)-8.69%
Max Revenue beat(4)8.39%
Revenue beat(8)4
Avg Revenue beat(8)-0.47%
Revenue beat(12)4
Avg Revenue beat(12)-1.94%
Revenue beat(16)6
Avg Revenue beat(16)-0.69%
PT rev (1m)2.4%
PT rev (3m)-2.98%
EPS NQ rev (1m)-72.33%
EPS NQ rev (3m)-1820.41%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.77%
Revenue NQ rev (1m)-0.16%
Revenue NQ rev (3m)-2.14%
Revenue NY rev (1m)-0.51%
Revenue NY rev (3m)-0.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 100.39
P/S 1.86
P/FCF N/A
P/OCF 11.92
P/B 0.91
P/tB 1.11
EV/EBITDA 26.05
EPS(TTM)-2.71
EYN/A
EPS(NY)0.79
Fwd EY1%
FCF(TTM)-1.54
FCFYN/A
OCF(TTM)6.62
OCFY8.39%
SpS42.44
BVpS87.03
TBVpS70.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.34%
ROE -10.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.76%
FCFM N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 7.46
Cap/Depr 146.27%
Cap/Sales 19.25%
Interest Coverage N/A
Cash Conversion 182.86%
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 1.47
Altman-Z 1.65
F-Score4
WACC8.38%
ROIC/WACCN/A
Cap/Depr(3y)401.9%
Cap/Depr(5y)389.55%
Cap/Sales(3y)23.64%
Cap/Sales(5y)25.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-155.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
EPS Next Y33.75%
EPS Next 2Y52.84%
EPS Next 3Y58.22%
EPS Next 5Y63.36%
Revenue 1Y (TTM)-33.05%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-7.02%
Revenue Next Year-11.82%
Revenue Next 2Y-2.15%
Revenue Next 3Y3.93%
Revenue Next 5Y11.24%
EBIT growth 1Y79.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year157.47%
EBIT Next 3Y43.09%
EBIT Next 5Y36.66%
FCF growth 1Y-118.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.5%
OCF growth 3Y26.81%
OCF growth 5Y-0.49%